Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Operating Leases (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Operating Leases for 2 consecutive years, with $17.0 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 9.07% to $17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Dec 2025, down 9.07% year-over-year, with the annual reading at $17.0 million for FY2025, 9.07% down from the prior year.
  • Operating Leases for Q4 2025 was $17.0 million at Pyxis Oncology, down from $17.4 million in the prior quarter.
  • The five-year high for Operating Leases was $19.8 million in Q1 2024, with the low at $17.0 million in Q4 2025.